4 2009年世界最畅销的抗感染药雅培制药的洛匹那韦与利托那韦的复方制剂Kaletra13.66亿美元(年度销售额排名第83位,下同);依非韦仑Sustiva12.77亿美元(95),由BMS销售散装依非韦仑8.69亿美 4 In 2009, the world’s best-selling anti-infective drug Abbott Laboratories Inc. produced a total of $ 1.366 billion of compound preparation of lopinavir and ritonavir (the 83rd annual sales volume, the same below); the non-efavirenz’s Sustiva12.77 Billion USD (95), sold by BMS to 899 million U.S. dollars of bulk efavirenz